Fronthera U.S. Pharmaceuticals LLC
Records under this name other than patents Fronthera U.S. Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Fronthera U.S. Pharmaceuticals LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,053,219 | Substituted Pyridines as TYK2 Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,964,964 | Thyroid Hormone Receptor Agonists and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,040,972 | Autotaxin inhibitors and uses thereof Formerly held Lapsed on the fee record Ended Jun 22, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 22, 2025 | USPTO record |
| US 11,034,671 | Apoptosis signal-regulating kinase inhibitors and uses thereof Formerly held Lapsed on the fee record Ended Jun 15, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 15, 2025 | USPTO record |
| US 10,787,430 | Hemoglobin modifier compounds and uses thereof Formerly held Lapsed on the fee record Ended Sep 29, 2024 · USPTO record | Lapsed on the fee record | Ended Sep 29, 2024 | USPTO record |
| US 10,711,000 | Autotaxin inhibitors and uses thereof Formerly held Lapsed on the fee record Ended Jul 14, 2024 · USPTO record | Lapsed on the fee record | Ended Jul 14, 2024 | USPTO record |